Publications

Detailed Information

Long-term Temporal Changes of Macular Thickness and Visual Outcome after Vitrectomy for Idiopathic Epiretinal Membrane

DC Field Value Language
dc.contributor.authorKim, Jongshin-
dc.contributor.authorRhee, Kyoung Min-
dc.contributor.authorWoo, Se Joon-
dc.contributor.authorYu, Young Suk-
dc.contributor.authorPark, Kyu Hyung-
dc.contributor.authorChung, Hum-
dc.date.accessioned2012-06-29T00:41:12Z-
dc.date.available2012-06-29T00:41:12Z-
dc.date.issued2010-11-
dc.identifier.citationAMERICAN JOURNAL OF OPHTHALMOLOGY; Vol.150 5; 701-709ko_KR
dc.identifier.issn0002-9394-
dc.identifier.urihttps://hdl.handle.net/10371/77847-
dc.description.abstractPURPOSE: To evaluate the long-term correlation of visual outcome and macular thickness after vitrectomy for idiopathic epiretinal membrane and to identify prognostic factors for good visual outcome. DESIGN: Retrospective, observational case series. METHODS: We reviewed the records of 52 patients with idiopathic epiretinal membrane who were treated with vitrectomy and could be followed up for more than 12 months. The main outcome measures were best-corrected visual acuity (BCVA) and central macular thickness at baseline; at 1, 3, 6, and 12 months after surgery; and at the final follow-up visit. The correlation between BCVA and central macular thickness was analyzed and the receiver operating characteristic curve analysis was performed to obtain cutoff values for visual prognosis. RESULTS: Most of the changes in BCVA and central macular thickness took place during the first 3 months and reached a plateau at 12 months after surgery. Despite the lack of changes in BCVA after 12 months of follow-up, significant reduction in central macular thickness could still be observed over 12 months after surgery. The final BCVA was correlated significantly with preoperative BCVA and central macular thickness and early postoperative central macular thickness. Among them, the postoperative central macular thickness at 1 month showed the largest area under the receiver operating characteristic curve. CONCLUSIONS: Given the removal of the confounding effect of cataract, postoperative follow-up of 12 months may be sufficient to reach the final BCVA after surgery. However, more time is needed to achieve final central macular thickness. Because of the significant correlation between final BCVA and early postoperative central macular thickness, serial optical coherence tomography images in the early postoperative period were needed to predict visual outcome after epiretinal membrane removal. (Am J Ophthalmol 2010;150:701-709. (C) 2010 by Elsevier Inc. All rights reserved.)ko_KR
dc.language.isoenko_KR
dc.publisherELSEVIER SCIENCE INCko_KR
dc.titleLong-term Temporal Changes of Macular Thickness and Visual Outcome after Vitrectomy for Idiopathic Epiretinal Membraneko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor김종신-
dc.contributor.AlternativeAuthor이경민-
dc.contributor.AlternativeAuthor우세준-
dc.contributor.AlternativeAuthor유영석-
dc.contributor.AlternativeAuthor정흠-
dc.contributor.AlternativeAuthor박규형-
dc.identifier.doi10.1016/j.ajo.2010.05.037-
dc.citation.journaltitleAMERICAN JOURNAL OF OPHTHALMOLOGY-
dc.description.citedreferenceWolf-Schnurrbusch UEK, 2009, INVEST OPHTH VIS SCI, V50, P3432, DOI 10.1167/iovs.08-2970-
dc.description.citedreferenceAso H, 2009, ACTA OPHTHALMOL, V87, P419, DOI 10.1111/j.1755-3768.2008.01264.x-
dc.description.citedreferenceSuh MH, 2009, AM J OPHTHALMOL, V147, P473, DOI 10.1016/j.ajo.2008.09.020-
dc.description.citedreferenceMitamura Y, 2009, BRIT J OPHTHALMOL, V93, P171, DOI 10.1136/bjo.2008.146381-
dc.description.citedreferenceSnead DRJ, 2008, EYE, V22, P1310, DOI 10.1038/eye.2008.36-
dc.description.citedreferenceHassenstein A, 2005, OPHTHALMOLOGE, V102, P127, DOI 10.1007/s00347-004-1055-8-
dc.description.citedreferenceISHIDA M, 2004, NIPPON GANKA GAKKAI, V108, P18-
dc.description.citedreferenceMassin P, 2000, AM J OPHTHALMOL, V130, P732-
dc.description.citedreferenceMitchell P, 1997, OPHTHALMOLOGY, V104, P1033-
dc.description.citedreferenceWilkins JR, 1996, OPHTHALMOLOGY, V103, P2142-
dc.description.citedreferenceKLEIN R, 1994, T AM OPHTHAL SOC, V92, P403-
dc.description.citedreferencePESIN SR, 1991, OPHTHALMOLOGY, V98, P1109-
dc.description.citedreferenceCHERFAN GM, 1991, AM J OPHTHALMOL, V111, P434-
dc.description.citedreference*EARL TREATM DIAB, 1991, OPHTHALMOLOGY, V98, P741-
dc.description.citedreferenceDEBUSTROS S, 1988, BRIT J OPHTHALMOL, V72, P692-
dc.description.citedreferencePOLINER LS, 1988, ARCH OPHTHALMOL-CHIC, V106, P761-
dc.description.citedreferenceDEBUSTROS S, 1988, AM J OPHTHALMOL, V105, P160-
dc.description.citedreferenceRICE TA, 1986, OPHTHALMOLOGY, V93, P602-
dc.description.citedreferenceMARGHERIO RR, 1985, OPHTHALMOLOGY, V92, P1075-
dc.description.citedreferencePEARLSTONE AD, 1985, ANN OPHTHALMOL, V17, P378-
dc.description.citedreferenceTRESE M, 1983, GRAEF ARCH CLIN EXP, V221, P16-
dc.description.tc2-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share